Navigation Links
Ira Haimowitz, PhD, EVP, Group Director, Intelligence and Analytics at The CementBloc, to Present at Aberdeen Group Inaugural Business Analytics Summit
Date:11/10/2011

NEW YORK, Nov. 10, 2011 /PRNewswire/ -- Dr. Ira J. Haimowitz, Executive Vice President, Group Director, Intelligence and Analytics at The CementBloc, will be featured on an expert panel at the inaugural Business Analytics Summit, sponsored by the Aberdeen Group, at the Seaport Hotel in Boston on November 16, 2011.

The summit, titled "Driving New Insight for Line-of-Business Decisions," features the latest business thinkers, corporate leaders, and cutting-edge practices designed to provide insights into the improved visibility of business intelligence and analytics. Dr. Haimowitz will be participating in a panel entitled "Creating an Effective Partnership Between IT and Business." He will bring to the panel his unique perspective on the use of technology in pharmaceutical sales and marketing.

For over 20 years, Dr. Haimowitz has provided healthcare clients with innovative solutions for relationship marketing, segmentation, operations, measurement, and optimization. He has also enabled clients to evaluate the return on investment of their multichannel consumer and professional advertising campaigns.

Prior to joining The CementBloc, Dr. Haimowitz was Vice President, Group Director of Insights and Optimization at Wunderman, leading a team deploying analytics across healthcare, financial services, and consumer packaged goods. He has also spent 9 years on the manufacturer side as a director and team leader for pharmaceutical companies Pfizer and Organon.

Dr. Haimowitz received his PhD in computer science from Massachusetts Institute of Technology in 1994, and his MPhil from Cambridge University in computer speech and language processing. He has spoken and published extensively, and has also served for 7 years on the board of the Pharmaceutical Management Science Association, including a term as President in 2006. Dr. Haimowitz recently authored the book Healthcare Relationship Marketing, from Gower Press, and has a blog by the same name (http://healthcarerm.blogspot.com/).

For reservations to attend this presentation, call the Aberdeen Group at 617-854-5200.

About The CementBloc: The CementBloc is a leading multichannel health and wellness creative agency based in New York. Founded in 2000 by Susan Miller Viray and Rico Viray, The CementBloc is also a founding member of Indigenus, an independent global network of entrepreneurial healthcare creative agencies.

http://www.thecementbloc.com


'/>"/>
SOURCE The CementBloc
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Restrictive Compliance Environment Weakens Professional and Trade Relations Group Impact
2. Global Pharm Holdings Group, Inc. Completes Acquisition of Qingdao Likang Pharmaceutical Co., Ltd.
3. CRC Health Group Announces Acquisition of North Carolinas Mountain Health Solutions
4. Vermillion Engages Liolios Group to Lead Investor Relations Program
5. ArjoHuntleigh Awarded Vascular Compression Contract With HealthTrust Purchasing Group
6. Simcere Pharmaceutical Group to Announce Third Quarter 2011 Financial Results on Monday, November 14, 2011
7. Publicis Healthcare Communications Group Redefines Publicis Groupes Healthcare Client Offering by Joining Forces with Digitas Health and Razorfish Health
8. Herborium Group Shareholders Update
9. MiMedx Group Announces Third Quarter 2011 Results
10. Global Sources opens six trade shows with worlds top buyers registered to attend including Adidas, AEON, American Greetings, Brookstone, Casino, Coles Group, Mothercare, Next, Sears and Woolworths
11. Perrigo Expands Infant Formula Distribution in China With Founder Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
Breaking Medicine News(10 mins):